oleic acid has been researched along with losartan in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dumont, CJ; Grekin, RJ; Vollmer, AP; Watts, SW; Webb, RC | 1 |
Downton, M; Du, Y; Jia, Z; Liu, G; Liu, S; Liu, Y; Yang, T | 1 |
Chuang, PY; He, JC; Menon, MC | 1 |
4 other study(ies) available for oleic acid and losartan
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion.
Topics: Acetylcholine; Aldosterone; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Corticosterone; Epinephrine; Fatty Acids, Nonesterified; Heart Rate; Hypertension; Imidazoles; Infusions, Intravenous; Liver; Losartan; Male; Norepinephrine; Oleic Acid; Phenylephrine; Portal Vein; Prazosin; Rats; Rats, Sprague-Dawley; Renin; Serotonin; Sodium Fluoride; Tetrazoles; Time Factors | 1997 |
Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Humans; Losartan; Mice; Mice, Inbred C57BL; Oleic Acid; Renin-Angiotensin System | 2013 |
Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetic Nephropathies; Humans; Losartan; Oleic Acid | 2013 |